KYMR logo

Kymera Therapeutics (KYMR) Shareholders Equity

Annual Shareholders Equity

$835.62 M
+$440.65 M+111.56%

December 31, 2024


Summary


Performance

KYMR Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKYMRbalance sheetmetrics:

Quarterly Shareholders Equity

$835.62 M
-$57.31 M-6.42%

December 31, 2024


Summary


Performance

KYMR Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKYMRbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

KYMR Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+111.6%+111.6%
3 y3 years+81.8%+111.6%
5 y5 years+1223.0%+111.6%

KYMR Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+111.6%-6.4%+111.6%
5 y5-yearat high+1223.0%-6.4%+1223.0%
alltimeall timeat high+1223.0%-6.4%+1223.0%

Kymera Therapeutics Shareholders Equity History

DateAnnualQuarterly
Dec 2024
$835.62 M(+111.6%)
$835.62 M(-6.4%)
Sep 2024
-
$892.93 M(+30.4%)
Jun 2024
-
$684.92 M(-3.7%)
Mar 2024
-
$711.20 M(+80.1%)
Dec 2023
$394.97 M(-19.4%)
$394.97 M(-0.1%)
Sep 2023
-
$395.54 M(-9.2%)
Jun 2023
-
$435.43 M(-5.8%)
Mar 2023
-
$462.00 M(-5.7%)
Dec 2022
$490.15 M
$490.15 M(-4.4%)
Sep 2022
-
$512.88 M(+28.9%)
DateAnnualQuarterly
Jun 2022
-
$397.95 M(-7.2%)
Mar 2022
-
$428.72 M(-6.7%)
Dec 2021
$459.64 M(+61.9%)
$459.64 M(-4.9%)
Sep 2021
-
$483.13 M(+87.2%)
Jun 2021
-
$258.10 M(-6.2%)
Mar 2021
-
$275.25 M(-3.0%)
Dec 2020
$283.89 M(-481.5%)
$283.89 M(-3.7%)
Sep 2020
-
$294.69 M(+183.2%)
Jun 2020
-
$104.04 M(-239.8%)
Dec 2019
-$74.41 M(+116.1%)
-$74.41 M
Dec 2018
-$34.44 M
-

FAQ

  • What is Kymera Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Kymera Therapeutics?
  • What is Kymera Therapeutics annual shareholders equity year-on-year change?
  • What is Kymera Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Kymera Therapeutics?
  • What is Kymera Therapeutics quarterly shareholders equity year-on-year change?

What is Kymera Therapeutics annual stockholders equity?

The current annual shareholders equity of KYMR is $835.62 M

What is the all time high annual shareholders equity for Kymera Therapeutics?

Kymera Therapeutics all-time high annual stockholders equity is $835.62 M

What is Kymera Therapeutics annual shareholders equity year-on-year change?

Over the past year, KYMR annual stockholders equity has changed by +$440.65 M (+111.56%)

What is Kymera Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of KYMR is $835.62 M

What is the all time high quarterly shareholders equity for Kymera Therapeutics?

Kymera Therapeutics all-time high quarterly stockholders equity is $892.93 M

What is Kymera Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, KYMR quarterly stockholders equity has changed by +$440.65 M (+111.56%)